Cohort Study to Evaluate Fetal and Infant Outcomes Following Maternal Exposure to Bimekizumab during Pregnancy

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study

Study drug and medical condition

• Study drug International non-proprietary name (INN) or common name:
  BIMEKIZUMAB
• Anatomical Therapeutic Chemical (ATC) code:
  (L04AC21) bimekizumab

  bimekizumab